WANDA CACHO: Open Payments
NPI 1184296121 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 59 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $419 · 2025 $1,495
Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $285 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $224 |
| Astellas Pharma US Inc | 9 | $219 |
| AstraZeneca Pharmaceuticals LP | 2 | $148 |
| Lilly USA, LLC | 9 | $143 |
| Exact Sciences Corporation | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Indivior Inc. | 4 | $66 |
| Braeburn Inc. | 3 | $66 |
| Phadia US Inc. | 2 | $44 |
Products named: Kerendia, Veozah, Ozempic, MOUNJARO, WAINUA, Rybelsus, REXULTI, SUBLOCADE.
Industry payments across PA — which companies pay providers there.
